Long-term dual antithrombotic therapy (DAT): is it efficient and safe in women?

This editorial refers to ‘Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease’, by Y. Lianget al., pp.942 –949.
Source: Cardiovascular Research - Category: Cardiology Source Type: research